April 23 (Reuters) - Novartis (NOVN.S), opens new tab has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an asthma drug for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results